Europe GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell T

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,000	166 Pages	The Insight Partners	January, 2023	TIP17679665

Best Price Guarantee
Price	from $3,000
Length	166 Pages
Publisher	The Insight Partners
Published Date	January, 2023
SKU	TIP17679665

Europe GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)

The Europe GMP cell therapy consumables market is expected to grow from US$ 4,827.85 million in 2022 to US$ 20,569.16 million by 2028; it is estimated to grow at a CAGR of 27.2% from 2022 to 2028.

Rise in Research & Development and Drug Discovery Drives Europe GMP Cell Therapy Consumables Market

Drug discovery is a long process that comprises various steps such as early discovery, preclinical phase, clinical phase, and regulatory approval. The process tremendously involves the use of cell therapy consumables to achieve the desired results. According to the World Health Organization, ~10 million deaths due to cancer were recorded in 2020, and the most common types of cancer are breast cancer, lung cancer, colon cancer, rectum cancer, and prostate cancer. Various research studies have shown positive outcomes of drugs that can effectively treat cancer, neurological disorders, autoimmune disorders, and other chronic disorders. Therefore, the rising prevalence of chronic disorders propels the demand for research and development(R&D) activities. In addition, the growing incidence of various rare disorders such as amyloidosis, Adrenoleukodystrophy, and Ehlers-Danlos syndrome has increased the R&D activities for drug development.

Moreover, numerous biotechnology companies operating in the GMP cell therapy consumables market are collaborating to accelerate R&D activities on a global level. For instance, in October 2022, Century Therapeutics and Bristol Myers Squibb announced the research collaboration and license agreement to develop and commercialize up to four induced pluripotent stem cells (“iPSC”) derived, engineered natural killer cell (“iNK”) and/or T cell (“iT”) programs for hematologic malignancies and solid tumors. Additionally, the rising demand for personalized and regenerative medicine has boosted the growth of the cell therapy consumables market. Thus, an increase in research & development activities along with a surge in drug discovery has tremendously increased the use of GMP cell therapy consumables, which is driving the growth of the GMP cell therapy consumables market across the region.

Europe GMP Cell Therapy Consumables Market Overview

The Europe GMP cell therapy consumables market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global GMP cell therapy consumables market. The market growth in the region is due to increasing healthcare expenditure, rising incidence of cancer, increasing health awareness, and growing research and development. Germany is considered among the fastest-growing GMP cell therapy consumables market in Europe. The growing importance of GMP cell therapy consumables, along with the expansion of regional players, is aiding the market growth in Germany. Further, The Federal Statistical Office reported an increase in health expenditure in Germany which aids in research and development in the healthcare sector. According to German Trade and Invest (GTAI), Germany's biotech industry has been rapidly expanding for some years. On average, more than 710 companies are engaged in the biotechnology sector. Overall, the biotech sector revenue is increased by 36%, while R&D spending has increased by 37%. Germany has experienced a growth in the number of innovative pharmaceutical companies, drug manufacturers, contract research organizations (CROs), and small- and medium-sized biopharmaceutical companies.

Further, there have been remarkable innovations in the cell therapy segment in Germany. For instance, in 2021, Germany’s Federal Institute for Vaccines and Biomedicines (Paul-Ehrlich-Institut) granted RHEACELL national approval for its cell therapy product—AMESANAR—for use in patients having chronic wounds. Similarly, in June 2022, Bayer’s BlueRock Therapeutics established a European site for cell therapy innovation. BlueRock is currently engaged in a Phase I clinical trial for its novel cell therapy, BRT-DA01, for treating Parkinson’s disease. The rising government health expenditure, growing expansion of global players in Germany, and increasing product development by manufacturers are boosting the application of GMP cell therapy consumables, which is also boosting the growth of the Europe GMP cell therapy consumables market.

Europe GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)

Europe GMP Cell Therapy Consumables Market Segmentation

The Europe GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.

Based on product, the GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the Europe GMP cell therapy consumables market in 2022.

Based on cell therapy, the GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the Europe GMP cell therapy consumables market in 2022. Based on process, the market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the Europe GMP cell therapy consumables market in 2022. Based on end use, the market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the Europe GMP cell therapy consumables market in 2022. Based on country, the Europe GMP cell therapy consumables market is segmented into France, Italy, Germany, Spain, the UK, and the Rest of Europe. Germany dominated the Europe GMP cell therapy consumables market in 2022. Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the Europe cell therapy consumables market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe GMP cell therapy consumables market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

1. Introduction: 1.1 Study Scope; 1.2 The Insight Partners Research Report Guidance; 1.3 Market Segmentation; 1.3.1 Europe GMP Cell Therapy Consumables Market – by Product; 1.3.2 Europe GMP Cell Therapy Consumables Market – by Cell Therapy; 1.3.3 Europe GMP Cell Therapy Consumables Market – by End Use; 1.3.4 Europe GMP Cell Therapy Consumables Market – by End Use; 1.3.5 Europe GMP Cell Therapy Consumables Market – by Country
2. Europe GMP Cell Therapy Consumables Market – Key Takeaways
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. Europe GMP Cell Therapy Consumables Market – Market Landscape: 4.1 Overview; 4.2 Europe PEST Analysis; 4.3 Experts’ Opinion
5. Europe GMP Cell Therapy Consumables Market – Key Market Dynamics: 5.1 Market Drivers; 5.1.1 Rise in Research & Development and Drug Discovery; 5.1.2 Increase in Strategic Collaborations; 5.2 Market Restraints; 5.2.1 Stringent Regulatory Policies; 5.3 Future Trends; 5.3.1 Increasing Clinical Trials and Rising GMP Demand; 5.4 Impact Analysis
6. GMP Cell Therapy Consumables Market – Europe Analysis: 6.1 Europe GMP Cell Therapy Consumables Market Revenue Forecast and Analysis
7. Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Product: 7.1 Overview; 7.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%); 7.3 Kits; 7.3.1 Overview; 7.3.2 Kits: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 7.4 Reagents/ Molecular Biology Reagents; 7.4.1 Overview; 7.4.2 Reagents/ Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers); 7.5.1 Overview; 7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 7.6 Others; 7.6.1 Overview; 7.6.2 Others: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 – by Cell Therapy: 8.1 Overview; 8.2 Europe GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%); 8.3 NK Cell Therapy; 8.3.1 Overview; 8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 8.4 Stem Cell Therapy; 8.4.1 Overview; 8.4.2 Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 8.5 T-cell Therapy; 8.5.1 Overview; 8.5.2 T-cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 8.6 Others; 8.6.1 Overview; 8.6.2 Others: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by End Use: 9.1 Overview; 9.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%); 9.3 Clinical; 9.3.1 Overview; 9.3.2 Clinical: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 9.4 Commercial; 9.4.1 Overview; 9.4.2 Commercial: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 9.5 Research; 9.5.1 Overview; 9.5.2 Research: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Process: 10.1 Overview; 10.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%); 10.3 Cell Collection and Characterization/Sorting and Separation; 10.3.1 Overview; 10.3.2 Cell Collection and Characterization/ Sorting and Separation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.4 Cell Culture and Expansion/Preparation; 10.4.1 Overview; 10.4.2 Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.5 Cryopreservation; 10.5.1 Overview; 10.5.2 Cryopreservation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.6 Cell Processing and Formulation; 10.6.1 Overview; 10.6.2 Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.7 Cell Isolation and Activation; 10.7.1 Overview; 10.7.2 Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.8 Cell Distribution/Handling; 10.8.1 Overview; 10.8.2 Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.9 Process Monitoring and Control/Readministration/Quality Assurance; 10.9.1 Overview; 10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 10.10 Other; 10.10.1 Overview; 10.10.2 Other: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – Country Analysis: 11.1 Overview; 11.1.1 Europe: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%); 11.1.1.1 Germany: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.1 Overview; 11.1.1.1.2 Germany: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.3 Germany: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million); 11.1.1.1.4 Germany: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million); 11.1.1.1.5 Germany: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million); 11.1.1.1.6 Germany: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million); 11.1.1.2 UK: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.1 Overview; 11.1.1.2.2 UK: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.3 UK: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million); 11.1.1.2.4 UK: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million); 11.1.1.2.5 UK: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million); 11.1.1.2.6 UK: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million); 11.1.1.3 France: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.1 Overview; 11.1.1.3.2 France: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.3 France: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million); 11.1.1.3.4 France: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million); 11.1.1.3.5 France: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million); 11.1.1.3.6 France: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million); 11.1.1.4 Italy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.1 Overview; 11.1.1.4.2 Italy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.3 Italy: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million); 11.1.1.4.4 Italy: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million); 11.1.1.4.5 Italy: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million); 11.1.1.4.6 Italy: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million); 11.1.1.5 Spain: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.1 Overview; 11.1.1.5.2 Spain: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.3 Spain: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million); 11.1.1.5.4 Spain: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million); 11.1.1.5.5 Spain: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million); 11.1.1.5.6 Spain: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million); 11.1.1.6 Rest of Europe: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.1 Overview; 11.1.1.6.2 Rest of Europe: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.3 Rest of Europe: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ Million); 11.1.1.6.4 Rest of Europe: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ Million); 11.1.1.6.5 Rest of Europe: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ Million); 11.1.1.6.6 Rest of Europe: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ Million)
12. GMP Cell Therapy Consumables Market – Industry Landscape: 12.1 Overview; 12.2 Growth Strategies in GMP Cell Therapy Consumables Market; 12.3 Inorganic Growth Strategies; 12.3.1 Overview; 12.4 Organic Growth Strategies; 12.4.1 Overview
13. Company Profiles: 13.1 Sartorius AG; 13.1.1 Key Facts; 13.1.2 Business Description; 13.1.3 Products and Services; 13.1.4 Financial Overview; 13.1.5 SWOT Analysis; 13.1.6 Key Developments; 13.2 Thermo Fisher Scientific Inc; 13.2.1 Key Facts; 13.2.2 Business Description; 13.2.3 Products and Services; 13.2.4 Financial Overview; 13.2.5 SWOT Analysis; 13.2.6 Key Developments; 13.3 Miltenyi Biotec BV & Co KG; 13.3.1 Key Facts; 13.3.2 Business Description; 13.3.3 Products and Services; 13.3.4 Financial Overview; 13.3.5 SWOT Analysis; 13.3.6 Key Developments; 13.4 Bio-Techne Corp; 13.4.1 Key Facts; 13.4.2 Business Description; 13.4.3 Products and Services; 13.4.4 Financial Overview; 13.4.5 SWOT Analysis; 13.4.6 Key Developments; 13.5 Corning Inc; 13.5.1 Key Facts; 13.5.2 Business Description; 13.5.3 Products and Services; 13.5.4 Financial Overview; 13.5.5 SWOT Analysis; 13.5.6 Key Developments; 13.6 FUJIFILM Irvine Scientific Inc; 13.6.1 Key Facts; 13.6.2 Business Description; 13.6.3 Products and Services; 13.6.4 Financial Overview; 13.6.5 SWOT Analysis; 13.6.6 Key Developments; 13.7 Lonza Group AG; 13.7.1 Key Facts; 13.7.2 Business Description; 13.7.3 Products and Services; 13.7.4 Financial Overview; 13.7.5 SWOT Analysis; 13.7.6 Key Developments; 13.8 BPS Bioscience Inc; 13.8.1 Key Facts; 13.8.2 Business Description; 13.8.3 Products and Services; 13.8.4 Financial Overview; 13.8.5 SWOT Analysis; 13.8.6 Key Developments; 13.9 Merck KGaA; 13.9.1 Key Facts; 13.9.2 Business Description; 13.9.3 Products and Services; 13.9.4 Financial Overview; 13.9.5 SWOT Analysis; 13.9.6 Key Developments; 13.10 Global Life Sciences Solutions USA LLC; 13.10.1 Key Facts; 13.10.2 Business Description; 13.10.3 Products and Services; 13.10.4 Financial Overview; 13.10.5 SWOT Analysis; 13.10.6 Key Developments
14. Appendix: 14.1 About The Insight Partners; 14.2 Glossary of Terms
LIST OF TABLES
: Table 1. Germany GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million); Table 2. Germany GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million); Table 3. Germany GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million); Table 4. Germany GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million); Table 5. UK GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million); Table 6. UK GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million); Table 7. UK GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million); Table 8. UK GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million); Table 9. France GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million); Table 10. France GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million); Table 11. France GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million); Table 12. France GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million); Table 13. Italy GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million); Table 14. Italy GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million); Table 15. Italy GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million); Table 16. Italy GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million); Table 17. Spain GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million); Table 18. Spain GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million); Table 19. Spain GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million); Table 20. Spain GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million); Table 21. Rest of Europe GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ Million); Table 22. Rest of Europe GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ Million); Table 23. Rest of Europe GMP Cell Therapy Consumables Market, by End Use – Revenue and Forecast to 2028 (US$ Million); Table 24. Rest of Europe GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ Million); Table 25. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market; Table 26. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market; Table 27. Glossary of Terms
LIST OF FIGURES
: Figure 1. Europe GMP Cell Therapy Consumables Market Segmentation; Figure 2. Europe GMP Cell Therapy Consumables Market, by Country; Figure 3. Europe GMP Cell Therapy Consumables Market Overview; Figure 4. Kits Segment Held the Largest Share of Product Segment in Europe GMP Cell Therapy Consumables Market; Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period; Figure 6. Europe: PEST Analysis; Figure 7. Experts’ Opinion; Figure 8. Europe GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints; Figure 9. Europe GMP Cell Therapy Consumables Market – Revenue Forecast and Analysis – 2019–2028; Figure 10. Europe GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%); Figure 11. Kits: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 12. Reagents/ Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 14. Others: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 15. Europe GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%); Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 17. Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 18. T-cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 19. Other Applications: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 20. Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%); Figure 21. Clinical: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 22. Commercial: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 23. Research: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 24. Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%); Figure 25. Cell Collection and Characterization/Sorting and Separation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 26. Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 27. Cryopreservation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 28. Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 29. Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 30. Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 32. Other: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 33. Europe: GMP Cell Therapy Consumables Market, by Key Country – Revenue (2021) (US$ Million); Figure 34. Europe: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%); Figure 35. Germany: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 36. UK: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 37. France: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 38. Italy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 39. Spain: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 40. Rest of Europe: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million); Figure 41. Growth Strategies in GMP Cell Therapy Consumables Market